Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

FDA Grants Marketing Authorization To Cepheid For Xpert HCV Test And GeneXpert Xpress System, First Point-Of-Care Hepatitis C Test

Author: Benzinga Newsdesk | June 27, 2024 03:16pm

https://www.prnewswire.com/news-releases/fda-permits-marketing-of-first-point-of-care-hepatitis-c-rna-test-302185013.html

Posted In: DHR